CareerContact usPartners

Transbronchical BIOPSY’s current limitations have major consequences.

Staggering error rates in repeat procedures, delayed diagnoses, more expensive and invasive treatments.

44%

ERROR RATE

in small nodule diagnosis, mostly attributable to outdated technology

38%

of all cancer-related medical malpractice claims in 2019 were due to lung cancer misdiagnoses